Legal & General Group
DNA icon

Legal & General Group’s Ginkgo Bioworks DNA Stock Holding History

Legal & General Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2M Buy
1,661,587
+83,660
+5% +$696K ﹤0.01% 1109
2025
Q4 		$13.1M Sell
1,577,927
-30,996
-2% -$334K ﹤0.01% 1016
2025
Q3 		$23.5M Buy
1,608,923
+118,402
+8% +$1.42M 0.01% 808
2025
Q2 		$16.8M Buy
1,490,521
+71,927
+5% +$557K ﹤0.01% 927
2025
Q1 		$8.09M Buy
1,418,594
+567,173
+67% +$5.78M ﹤0.01% 1257
2024
Q4 		$8.37M Sell
851,421
-575,077
-40% -$4.93M ﹤0.01% 1287
2024
Q3 		$11.5M Buy
1,426,498
+754,800
+112% +$7.56M ﹤0.01% 1106
2024
Q2 		$8.86M Buy
671,698
+385,753
+135% +$11.5M ﹤0.01% 1187
2024
Q1 		$13.4M Buy
285,945
+246,676
+628% +$12.8M ﹤0.01% 998
2023
Q4 		$2.65M Buy
39,269
+370
+1% +$22.7K ﹤0.01% 1808
2023
Q3 		$2.82M Buy
38,899
+17,058
+78% +$1.36M ﹤0.01% 1741
2023
Q2 		$1.62M Buy
21,841
+3,196
+17% +$189K ﹤0.01% 2015
2023
Q1 		$992K Buy
18,645
+661
+4% +$41.9K ﹤0.01% 2155
2022
Q4 		$1.22M Buy
17,984
+3,326
+23% +$306K ﹤0.01% 2092
2022
Q3 		$1.83M Buy
14,658
+8,370
+133% +$997K ﹤0.01% 1899
2022
Q2 		$599K Buy
+6,288
New +$767K ﹤0.01% 2302

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Legal & General Group's DNA Position: Q1 2026 in Review

Legal & General Group increased its Ginkgo Bioworks (DNA) stake by 5.3% in Q1 2026, buying an estimated $696K and bringing the position to 1,661,587 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1109.

Legal & General Group first reported a position in DNA in Q2 2022 and has held it in 16 quarters since. The position peaked at $23.5M in Q3 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Legal & General Group held 1,661,587 shares of Ginkgo Bioworks worth $10.2M as of Q1 2026.
  • Legal & General Group bought 83,660 Ginkgo Bioworks shares in Q1 2026, an estimated $696K.
  • Ginkgo Bioworks made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1109 holding.
  • Legal & General Group first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 16 quarters since.
  • Legal & General Group's Ginkgo Bioworks position peaked at $23.5M in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.